Literature DB >> 2178658

Electrophysiological basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias.

L Belardinelli1, B B Lerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2178658      PMCID： PMC1024304          DOI： 10.1136/hrt.63.1.3

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  19 in total

1.  On the mechanism of activation of muscarinic K+ channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins.

Authors:  Y Kurachi; T Nakajima; T Sugimoto
Journal:  Pflugers Arch       Date:  1986-09       Impact factor: 3.657

2.  Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children.

Authors:  J Till; E A Shinebourne; M L Rigby; B Clarke; D E Ward; E Rowland
Journal:  Br Heart J       Date:  1989-09

3.  Atropine resistant post infarction complete AV block: possible role of adenosine and improvement with aminophylline.

Authors:  P K Shah; P Nalos; T Peter
Journal:  Am Heart J       Date:  1987-01       Impact factor: 4.749

4.  Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity.

Authors:  B B Lerman; L Belardinelli; G A West; R M Berne; J P DiMarco
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

5.  Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: possible role of adenosine.

Authors:  R C Wesley; B B Lerman; J P DiMarco; R M Berne; L Belardinelli
Journal:  J Am Coll Cardiol       Date:  1986-11       Impact factor: 24.094

6.  Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.

Authors:  J P diMarco; T D Sellers; B B Lerman; M L Greenberg; R M Berne; L Belardinelli
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

7.  Ionic basis for the antagonism between adenosine and isoproterenol on isolated mammalian ventricular myocytes.

Authors:  G Isenberg; L Belardinelli
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

8.  Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes.

Authors:  L Belardinelli; G Isenberg
Journal:  Circ Res       Date:  1983-09       Impact factor: 17.367

9.  Actions of adenosine on normal and abnormal impulse initiation in canine ventricle.

Authors:  M R Rosen; P Danilo; R M Weiss
Journal:  Am J Physiol       Date:  1983-05

10.  Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardia.

Authors:  A Munoz; A Leenhardt; A Sassine; P Galley; P Puech
Journal:  Eur Heart J       Date:  1984-09       Impact factor: 29.983
View more
  4 in total

1.  A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig.

Authors:  S Snowdy; H X Liang; B Blackburn; R Lum; M Nelson; L Wang; J Pfister; B P Sharma; A Wolff; L Belardinelli
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 2.  The therapeutic and diagnostic cardiac electrophysiological uses of adenosine.

Authors:  A D Malcolm; C J Garratt; A J Camm
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

Review 3.  Regulation of atherosclerosis and associated risk factors by adenosine and adenosine receptors.

Authors:  Milka Koupenova; Hillary Johnston-Cox; Katya Ravid
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 4.  Adenosine A3 Receptor: A promising therapeutic target in cardiovascular disease.

Authors:  Shamama Nishat; Luqman A Khan; Zafar M Ansari; Seemi F Basir
Journal:  Curr Cardiol Rev       Date:  2016
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.